GOA Therapeutics Corp, 2026-11-05
A new SEC Form D private-offering notice from West Palm Beach, FL, a $225,000,000 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical-stage biopharmaceutical company developing GOA26, a first-in-class intravenous drug candidate for acute alcohol intoxication and poisoning.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Bamboo Creative Solutions LLC, 2026-11-09, $5.1M, Miami, FL
- Life Impact Partners 8 LLC, 2026-11-06, $5M, Draper, UT
- Shader Effects Inc, 2026-11-06, $350K, Winter Garden, FL
- BridgeHealth Pharmaceuticals, Inc., 2026-11-05, $3.5M, Woburn, MA
- Six/Ten Group, LLC, 2026-11-06, $30M, Winter Haven, FL
- Conexeu Sciences Inc., 2026-11-05, $22K, Reno, NV
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.